Johnson & Johnson enter final stage COVID-19 vaccine trial with 60,000 volunteers

Johnson & Johnson has begun final stage testing of its COVID-19 vaccine candidate. The company will trial the vaccine with 60,000 volunteers from around the world including participants from the US, South Africa, Brazil, Argentina, Columbia, and Chile. Johnson & Johnson’s vaccine joins candidates developed by Moderna, Pfizer and BioNTech, AstraZeneca and the University of Oxford in beginning the final stage of development.

Source: Businesswire